mayo clinic tirzepatide Mounjaro (Tirzepatide) Primary Care in Rochester and

While participants receiving tirzepatide as part of the SURMOUNT-1 trial achieved up to 22.5% weight loss, compared with 2.4% for the placebo group [26], it is prudent to review the comparative effectiveness of similar products currently on the market

Aim for at least 8 to 10 glasses of fluid daily during episodes, with at least half coming from electrolyte-containing sources

Joint stiffness is common after menopause and GLP-1 side effects like fatigue can make it worse

10.1038/s41392-024-01931-z 95 ZhouD.ChenY.-W.ZhaoZ.-H.YangR.-X.XinF.-Z.LiuX.-L.et al (2018)

Patients then assume tirzepatide doesnt agree with them, when its often the combination of dose + meal type + portion size